Capricor Therapeutics Stock Technical Analysis
CAPR Stock | USD 5.04 0.22 4.56% |
As of the 25th of April, Capricor Therapeutics shows the Risk Adjusted Performance of 0.0619, mean deviation of 2.85, and Downside Deviation of 3.56. Capricor Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Capricor Therapeutics, which can be compared to its peers. Please confirm Capricor Therapeutics coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Capricor Therapeutics is priced correctly, providing market reflects its regular price of 5.04 per share. Given that Capricor Therapeutics has jensen alpha of 0.2489, we suggest you to validate Capricor Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Capricor Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Capricor, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CapricorCapricor |
Capricor Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
22.33 | Strong Buy | 4 | Odds |
Most Capricor analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Capricor stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Capricor Therapeutics, talking to its executives and customers, or listening to Capricor conference calls.
Capricor Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Capricor Therapeutics Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Capricor Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Capricor Therapeutics Trend Analysis
Use this graph to draw trend lines for Capricor Therapeutics. You can use it to identify possible trend reversals for Capricor Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Capricor Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Capricor Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Capricor Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.05 , which means Capricor Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 87.27, which is the sum of squared deviations for the predicted Capricor Therapeutics price change compared to its average price change.About Capricor Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Capricor Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Capricor Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Capricor Therapeutics price pattern first instead of the macroeconomic environment surrounding Capricor Therapeutics. By analyzing Capricor Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Capricor Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Capricor Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 5.07 | 3.57 | 3.98 | 3.78 | Receivables Turnover | 0.63 | 4.65 | 2.43 | 2.31 |
Capricor Therapeutics April 25, 2024 Technical Indicators
Most technical analysis of Capricor help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Capricor from various momentum indicators to cycle indicators. When you analyze Capricor charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0619 | |||
Market Risk Adjusted Performance | 0.3211 | |||
Mean Deviation | 2.85 | |||
Semi Deviation | 3.23 | |||
Downside Deviation | 3.56 | |||
Coefficient Of Variation | 1167.42 | |||
Standard Deviation | 4.12 | |||
Variance | 16.98 | |||
Information Ratio | 0.0625 | |||
Jensen Alpha | 0.2489 | |||
Total Risk Alpha | (0.22) | |||
Sortino Ratio | 0.0724 | |||
Treynor Ratio | 0.3111 | |||
Maximum Drawdown | 25.87 | |||
Value At Risk | (6.24) | |||
Potential Upside | 7.29 | |||
Downside Variance | 12.66 | |||
Semi Variance | 10.44 | |||
Expected Short fall | (3.04) | |||
Skewness | 1.04 | |||
Kurtosis | 3.38 |
Capricor Therapeutics April 25, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Capricor stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 105,809 | ||
Daily Balance Of Power | 0.34 | ||
Rate Of Daily Change | 1.05 | ||
Day Median Price | 5.33 | ||
Day Typical Price | 5.23 | ||
Price Action Indicator | (0.18) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Capricor Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Capricor Stock, please use our How to Invest in Capricor Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Capricor Stock analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Capricor Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Capricor Therapeutics. If investors know Capricor will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Capricor Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 0.94 | Quarterly Revenue Growth 11.593 | Return On Assets (0.28) | Return On Equity (1.30) |
The market value of Capricor Therapeutics is measured differently than its book value, which is the value of Capricor that is recorded on the company's balance sheet. Investors also form their own opinion of Capricor Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Capricor Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Capricor Therapeutics' market value can be influenced by many factors that don't directly affect Capricor Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Capricor Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Capricor Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Capricor Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.